149 related articles for article (PubMed ID: 29695559)
1. Amentoflavone Inhibits ERK-modulated Tumor Progression in Hepatocellular Carcinoma
Lee KC; Tsai JJ; Tseng CW; Kuo YC; Chuang YC; Lin SS; Hsu FT
In Vivo; 2018; 32(3):549-554. PubMed ID: 29695559
[TBL] [Abstract][Full Text] [Related]
2. Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation.
Lee KC; Chen WT; Liu YC; Lin SS; Hsu FT
In Vivo; 2018; 32(5):1097-1103. PubMed ID: 30150431
[TBL] [Abstract][Full Text] [Related]
3. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.
Pan PJ; Tsai JJ; Liu YC
Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
[TBL] [Abstract][Full Text] [Related]
5. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells.
Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS
In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689
[TBL] [Abstract][Full Text] [Related]
6. Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma
Tsai JJ; Hsu FT; Pan PJ; Chen CW; Kuo YC
Anticancer Res; 2018 Apr; 38(4):2119-2125. PubMed ID: 29599330
[TBL] [Abstract][Full Text] [Related]
7. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
Tsai JJ; Pan PJ; Hsu FT
Oncol Rep; 2017 Feb; 37(2):1036-1044. PubMed ID: 28000898
[TBL] [Abstract][Full Text] [Related]
8. Suppression of ERK/NF-κB Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression
Lee YJ; Chung JG; Chien YT; Lin SS; Hsu FT
Anticancer Res; 2019 Jul; 39(7):3669-3675. PubMed ID: 31262893
[TBL] [Abstract][Full Text] [Related]
9. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
Weng MC; Wang MH; Tsai JJ; Kuo YC; Liu YC; Hsu FT; Wang HE
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29535278
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib.
Yang CJ; Wu MH; Tsai JJ; Hsu FT; Hsia TC; Liu KC; Kuo YC
Anticancer Res; 2022 May; 42(5):2495-2505. PubMed ID: 35489726
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
13. Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin.
Chen CH; Huang YC; Lee YH; Tan ZL; Tsai CJ; Chuang YC; Tu HF; Liu TC; Hsu FT
Anticancer Res; 2020 Dec; 40(12):6723-6732. PubMed ID: 33288565
[TBL] [Abstract][Full Text] [Related]
14. Amentoflavone Induces Cell-cycle Arrest, Apoptosis, and Invasion Inhibition in Non-small Cell Lung Cancer Cells.
Chen WT; Chen CH; Su HT; Yueh PF; Hsu FT; Chiang IT
Anticancer Res; 2021 Mar; 41(3):1357-1364. PubMed ID: 33788727
[TBL] [Abstract][Full Text] [Related]
15. Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF-
Hsu FT; Chiang IT; Kuo YC; Hsia TC; Lin CC; Liu YC; Chung JG
Am J Chin Med; 2019; 47(4):913-931. PubMed ID: 31096773
[TBL] [Abstract][Full Text] [Related]
16. Amentoflavone Induces Anti-angiogenic and Anti-metastatic Effects Through Suppression of NF-κB Activation in MCF-7 cells.
Chen JH; Chen WL; Liu YC
Anticancer Res; 2015 Dec; 35(12):6685-93. PubMed ID: 26637885
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.
Chen JC; Chuang HY; Hsu FT; Chen YC; Chien YC; Hwang JJ
Oncotarget; 2016 Dec; 7(51):85450-85463. PubMed ID: 27863427
[TBL] [Abstract][Full Text] [Related]
18. SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma.
Zhang Z; Yan Z; Yuan Z; Sun Y; He H; Mai C
Tumour Biol; 2015 Mar; 36(3):1503-9. PubMed ID: 25537088
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizic Acid Modulates Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits Protein Kinase B- and Extracellular Signal-Regulated Kinase-Mediated Metastatic Potential in Hepatocellular Carcinoma
Tsai JJ; Pan PJ; Hsu FT; Chung JG; Chiang IT
Am J Chin Med; 2020; 48(1):223-244. PubMed ID: 32054305
[TBL] [Abstract][Full Text] [Related]
20. Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
Chen WT; Chen YK; Lin SS; Hsu FT
Anticancer Res; 2018 Apr; 38(4):2161-2167. PubMed ID: 29599335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
